Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

191

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Neuropathic Pain
Interventions
DRUG

SAR292833

"Pharmaceutical form: capsule~Route of administration: oral"

DRUG

placebo

"Pharmaceutical form:capsule~Route of administration: oral"

Trial Locations (61)

1083

Investigational Site Number 348001, Budapest

Investigational Site Number 348005, Budapest

1134

Investigational Site Number 348007, Budapest

1145

Investigational Site Number 348002, Budapest

2091

Investigational Site Number 804005, Kiev

4043

Investigational Site Number 348006, Debrecen

8900

Investigational Site Number 348003, Zalaegerszeg

10032

Investigational Site Number 840001, New York

10400

Investigational Site Number 203005, Prague

Investigational Site Number 203006, Prague

10530

Investigational Site Number 840040, Hartsdale

14618

Investigational Site Number 840033, Rochester

16602

Investigational Site Number 840044, Altoona

19505

Investigational Site Number 840018, Johnstown

27103

Investigational Site Number 840022, Winston-Salem

27612

Investigational Site Number 840015, Raleigh

33134

Investigational Site Number 840046, Coral Gables

33418

Investigational Site Number 840034, Palm Beach Gardens

34471

Investigational Site Number 840013, Ocala

37388

Investigational Site Number 840045, Tullahoma

43623

Investigational Site Number 840017, Toledo

46254

Investigational Site Number 840012, Indianapolis

47714

Investigational Site Number 840019, Evansville

63141

Investigational Site Number 840035, St Louis

75230

Investigational Site Number 840043, Dallas

75231

Investigational Site Number 840032, Dallas

77200

Investigational Site Number 203002, Olomouc

78731

Investigational Site Number 840006, Austin

87109

Investigational Site Number 840037, Albuquerque

89148

Investigational Site Number 840010, Las Vegas

92660

Investigational Site Number 840020, Newport Beach

92705

Investigational Site Number 840038, Santa Ana

92780

Investigational Site Number 840002, Tustin

92845

Investigational Site Number 840007, Garden Grove

97404

Investigational Site Number 703004, Banská Bystrica

98122

Investigational Site Number 840016, Seattle

117036

Investigational Site Number 643008, Moscow

123423

Investigational Site Number 643010, Moscow

127486

Investigational Site Number 643009, Moscow

129128

Investigational Site Number 643001, Moscow

150030

Investigational Site Number 643005, Yaroslavl

190068

Investigational Site Number 643013, Saint Petersburg

194044

Investigational Site Number 643003, Saint Petersburg

195112

Investigational Site Number 643014, Saint Petersburg

420021

Investigational Site Number 643006, Kazan'

420077

Investigational Site Number 643007, Kazan'

603126

Investigational Site Number 643004, Nizhny Novgorod

630054

Investigational Site Number 643012, Novosibirsk

85741-3565

Investigational Site Number 840014, Tucson

01702

Investigational Site Number 840042, Framingham

01104

Investigational Site Number 840004, Springfield

85-796

Investigational Site Number 616001, Bydgoszcz

10-022

Investigational Site Number 616002, Lublin

27-600

Investigational Site Number 616007, Sandomierz

87-800

Investigational Site Number 616004, Włocławek

Unknown

Investigational Site Number 643011, Moscow

Investigational Site Number 804003, Kyiv

01841

Investigational Site Number 703001, Dubnica nad Váhom

05342

Investigational Site Number 703003, Krompachy

02091

Investigational Site Number 804002, Kiev

04114

Investigational Site Number 804004, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY